Licensing deals news from FierceBiotech
News
ACT says it has found key to limitless blood supply
Advanced Cell Technology may be running out of cash, but the biotech still knows how to garner headlines around the world. The company is reporting that it has been able to gin quantities of red Read more...
BMS inks $710M development deal with PDL
Bristol-Myers Squibb is paying $30 million upfront in a licensing deal for PDL BioPharma's Read more...
2008's Billion-dollar deals (H1)
The first half of 2008 has drawn to a close, with deal-making still on a roll. In the first six months of this year, companies inked six pacts--both buyouts and licensing deals--that exceed the Read more...
PTC inks $437M pact with Genzyme
PTC Therapeutics has snared a rich licensing deal with Genzyme for its lead development program. Genzyme has agreed to pay $100 million up front for PTC124, which is in Phase IIb for Duchenne Read more...
Top 5 deals of the first half of 2007
Deal-making continued at a blistering pace in the first half of 2007, as drug giants snapped up promising therapies from smaller developers in order to beef up their pipelines. See the companies Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets